206269-47-8

Basic information

• Product Name: 1-(2',3',5'-tri-O-benzoyl-β-L-ribofuranosyl)-6-azauracil
• Synonyms: 1-(2',3',5'-tri-O-benzoyl-β-L-ribofuranosyl)-6-azauracil
• CAS NO: 206269-47-8
• Molecular Weight: 557.516
• Mol File: 206269-47-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-(2',3',5'-tri-O-benzoyl-β-L-ribofuranosyl)-6-azauracil(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2',3',5'-tri-O-benzoyl-β-L-ribofuranosyl)-6-azauracil(206269-47-8)
• EPA Substance Registry System: 1-(2',3',5'-tri-O-benzoyl-β-L-ribofuranosyl)-6-azauracil(206269-47-8)

Safety Data

• Hazardous Substances Data: 206269-47-8(Hazardous Substances Data)

Upstream product

• 461-89-2 6-azauracil 
• 3080-30-6 1-O-acetyl-2,3,5-tri-O-benzoyl-β-L-ribofuranose 
• 17331-61-2 3,5-bis(trimethylsilyloxy)-1,2,4-triazine 

Relevant articles and documents

An economical synthesis of D- and L-pyrimidine arabinoand ribonucleosides

The one-step synthesis of several β-D/L-arabino- and ribonucleosides was performed in good yields under reflux or microwave-assisted fusion method. A comparison of the two methods showed that better yields were obtained using the reflux conditions. Copyright Taylor and Francis Group, LLC.

Monocyclic L-Nucleosides, analogs and uses thereof

Novel monocyclic L-Nucleoside compounds have the general formula STR1 Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th1 and Th2 response.